血小板减少-话题@MedSci

#血小板减少#

161篇内容 | 5062人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302858, encodeId=054513028585c, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Stroke：血小板减少症与脑出血患者临床结局的关系, objectType=article, longId=205788, objectId=bdec205e88b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdec205e88b0, replyNumber=0, likeNumber=94, createdTime=2021-01-17, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdec205e88b0, moduleTitle=Stroke：血小板减少症与脑出血患者临床结局的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdec205e88b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302857, encodeId=61ec130285ef1, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, objectType=article, longId=203551, objectId=920d203551ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920d203551ad, replyNumber=0, likeNumber=84, createdTime=2020-11-21, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920d203551ad, moduleTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920d203551ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302856, encodeId=2e1213028567b, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=欧盟批准血小板减少症药物Doptelet, objectType=article, longId=202993, objectId=c063202993a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c063202993a6, replyNumber=0, likeNumber=88, createdTime=2020-11-08, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c063202993a6, moduleTitle=欧盟批准血小板减少症药物Doptelet, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c063202993a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302855, encodeId=4c03130285511, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=孤儿药avatrombopag用于化疗诱导的血小板减少症三期临床失败, objectType=article, longId=202056, objectId=81e420205666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81e420205666, replyNumber=0, likeNumber=79, createdTime=2020-10-15, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81e420205666, moduleTitle=孤儿药avatrombopag用于化疗诱导的血小板减少症三期临床失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81e420205666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302854, encodeId=da6b130285470, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：肝素诱导性血小板减少症的早期确诊方法！, objectType=article, longId=200859, objectId=9af32008595b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9af32008595b, replyNumber=0, likeNumber=107, createdTime=2020-09-19, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9af32008595b, moduleTitle=Blood：肝素诱导性血小板减少症的早期确诊方法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9af32008595b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302853, encodeId=e48c13028533b, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展, objectType=article, longId=200483, objectId=a181200483f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a181200483f7, replyNumber=0, likeNumber=85, createdTime=2020-09-11, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a181200483f7, moduleTitle=Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a181200483f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302852, encodeId=73801302852f6, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=韩国发生发热伴血小板减少综合征人际传播 5人感染, objectType=article, longId=199429, objectId=6cd119942965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd119942965, replyNumber=0, likeNumber=70, createdTime=2020-08-15, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd119942965, moduleTitle=韩国发生发热伴血小板减少综合征人际传播 5人感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd119942965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302851, encodeId=86f6130285145, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Brit J Heamatol：巨细胞病毒相关血小板减少症患者的特征和预后, objectType=article, longId=198831, objectId=3fea19883115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fea19883115, replyNumber=0, likeNumber=70, createdTime=2020-08-07, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fea19883115, moduleTitle=Brit J Heamatol：巨细胞病毒相关血小板减少症患者的特征和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fea19883115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302850, encodeId=5f351302850a8, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Cell Rep：国内学者在发热伴血小板减少综合征病毒诱发炎症反应研究方面取得新进展, objectType=article, longId=198187, objectId=40e219818eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e219818eb8, replyNumber=0, likeNumber=133, createdTime=2020-07-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e219818eb8, moduleTitle=Cell Rep：国内学者在发热伴血小板减少综合征病毒诱发炎症反应研究方面取得新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e219818eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302849, encodeId=f25713028490d, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Brit J Heamatol：新冠患者的迟发性血小板减少症, objectType=article, longId=196879, objectId=1eac1968e90e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eac1968e90e, replyNumber=0, likeNumber=73, createdTime=2020-07-03, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eac1968e90e, moduleTitle=Brit J Heamatol：新冠患者的迟发性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eac1968e90e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302848, encodeId=3ded13028480c, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况, objectType=article, longId=196747, objectId=6da7196e47c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6da7196e47c3, replyNumber=0, likeNumber=60, createdTime=2020-07-01, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6da7196e47c3, moduleTitle=Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6da7196e47c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302847, encodeId=6f04130284e82, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=如何识别肝素诱导的血小板减少症, objectType=article, longId=194561, objectId=d4a31945610f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4a31945610f, replyNumber=0, likeNumber=84, createdTime=2020-05-23, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4a31945610f, moduleTitle=如何识别肝素诱导的血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4a31945610f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302845, encodeId=34851302845e4, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Brit J Heamatol：实体恶性肿瘤患者中肝素诱导的血小板减少症发生率和预后, objectType=article, longId=193399, objectId=821819339912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821819339912, replyNumber=0, likeNumber=85, createdTime=2020-05-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821819339912, moduleTitle=Brit J Heamatol：实体恶性肿瘤患者中肝素诱导的血小板减少症发生率和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=821819339912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302846, encodeId=bbf31302846b4, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响, objectType=article, longId=193398, objectId=62cf19339899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cf19339899, replyNumber=0, likeNumber=97, createdTime=2020-05-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cf19339899, moduleTitle=Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cf19339899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302844, encodeId=870d13028448f, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET, objectType=article, longId=193385, objectId=69891933853e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69891933853e, replyNumber=0, likeNumber=66, createdTime=2020-05-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69891933853e, moduleTitle=中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69891933853e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302843, encodeId=12da1302843ad, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, objectType=article, longId=192508, objectId=a0bb192508e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0bb192508e2, replyNumber=0, likeNumber=70, createdTime=2020-04-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0bb192508e2, moduleTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0bb192508e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302842, encodeId=5946130284262, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险, objectType=article, longId=191502, objectId=e12c191502b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12c191502b7, replyNumber=0, likeNumber=0, createdTime=2020-04-07, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12c191502b7, moduleTitle=Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e12c191502b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302841, encodeId=2ca613028418d, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：芳香化酶是cereblon的新底物，参与IMiDs诱导性血小板减少症的发生, objectType=article, longId=191220, objectId=be9e191220bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be9e191220bc, replyNumber=0, likeNumber=76, createdTime=2020-04-03, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be9e191220bc, moduleTitle=Blood：芳香化酶是cereblon的新底物，参与IMiDs诱导性血小板减少症的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be9e191220bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302840, encodeId=500b130284012, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：AGK缺陷可导致巨核细胞分化异常和血小板减少症, objectType=article, longId=190746, objectId=41ba190e4638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ba190e4638, replyNumber=0, likeNumber=70, createdTime=2020-03-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ba190e4638, moduleTitle=Blood：AGK缺陷可导致巨核细胞分化异常和血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ba190e4638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302839, encodeId=66ee130283938, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Shionogi宣布在英国推出血小板生成素受体激动剂Mulpleo（lusutrombopag），用于接受侵入性治疗的慢性肝病成年患者的严重血小板减少症, objectType=article, longId=189673, objectId=433d1896e3eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=433d1896e3eb, replyNumber=0, likeNumber=63, createdTime=2020-03-12, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=433d1896e3eb, moduleTitle=Shionogi宣布在英国推出血小板生成素受体激动剂Mulpleo（lusutrombopag），用于接受侵入性治疗的慢性肝病成年患者的严重血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=433d1896e3eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血小板减少

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Stroke：血小板减少症与脑出血患者临床结局的关系

2021-01-17

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定

2020-11-21

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

欧盟批准血小板减少症药物Doptelet

2020-11-08

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

孤儿药avatrombopag用于化疗诱导的血小板减少症三期临床失败

2020-10-15

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：肝素诱导性血小板减少症的早期确诊方法！

2020-09-19

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展

2020-09-11

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

韩国发生发热伴血小板减少综合征人际传播 5人感染

2020-08-15

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Brit J Heamatol：巨细胞病毒相关血小板减少症患者的特征和预后

2020-08-07

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Cell Rep：国内学者在发热伴血小板减少综合征病毒诱发炎症反应研究方面取得新进展

2020-07-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Brit J Heamatol：新冠患者的迟发性血小板减少症

2020-07-03

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况

2020-07-01

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

如何识别肝素诱导的血小板减少症

2020-05-23

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Brit J Heamatol：实体恶性肿瘤患者中肝素诱导的血小板减少症发生率和预后

2020-05-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响

2020-05-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET

2020-05-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系

2020-04-20

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险

2020-04-07

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：芳香化酶是cereblon的新底物，参与IMiDs诱导性血小板减少症的发生

2020-04-03

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：AGK缺陷可导致巨核细胞分化异常和血小板减少症

2020-03-26

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Shionogi宣布在英国推出血小板生成素受体激动剂Mulpleo（lusutrombopag），用于接受侵入性治疗的慢性肝病成年患者的严重血小板减少症

2020-03-12

科室
- - 订阅+
  - 更多科室
工具
服务